Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Tornincasa

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Recenti Progressi in Medicina|June 16, 2026
Antonio Tornincasa, Michele Montedoro
Clinical Breast Cancer|March 5, 2022
Ocular Toxicity in Breast Cancer Management: Manual for The OncologistFabio Canino, Claudia Omarini, Krisida Cerma, et al.
Anticancer Research|May 31, 2024
Neoadjuvant Treatment for a cT4cN+ HER2+ Breast Cancer: Case Report of a Therapeutic SuccessMarco Gunnellini, Antonio Tornincasa, Michele Montedoro, et al.
Biomedicines|January 21, 2023
Targeting PI3K/AKT/mTOR Pathway in Breast Cancer: From Biology to Clinical ChallengesKrisida Cerma, Federico Piacentini, Luca Moscetti, et al.
International Journal of Molecular Sciences|March 13, 2024
Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer PatientsFabio Canino, Antonio Tornincasa, Stefania Bettelli, et al.
British Journal of Cancer|December 2, 2022
Correction: Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluationMaria Vittoria Dieci, Luisa Carbognin, Federica Miglietta, et al.
British Journal of Cancer|November 17, 2022
Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluationMaria Vittoria Dieci, Luisa Carbognin, Federica Miglietta, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Recenti Progressi in Medicina|June 16, 2026
Antonio Tornincasa, Michele Montedoro
Clinical Breast Cancer|March 5, 2022
Ocular Toxicity in Breast Cancer Management: Manual for The OncologistFabio Canino, Claudia Omarini, Krisida Cerma, et al.
Anticancer Research|May 31, 2024
Neoadjuvant Treatment for a cT4cN+ HER2+ Breast Cancer: Case Report of a Therapeutic SuccessMarco Gunnellini, Antonio Tornincasa, Michele Montedoro, et al.
Biomedicines|January 21, 2023
Targeting PI3K/AKT/mTOR Pathway in Breast Cancer: From Biology to Clinical ChallengesKrisida Cerma, Federico Piacentini, Luca Moscetti, et al.
International Journal of Molecular Sciences|March 13, 2024
Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer PatientsFabio Canino, Antonio Tornincasa, Stefania Bettelli, et al.
British Journal of Cancer|December 2, 2022
Correction: Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluationMaria Vittoria Dieci, Luisa Carbognin, Federica Miglietta, et al.
British Journal of Cancer|November 17, 2022
Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluationMaria Vittoria Dieci, Luisa Carbognin, Federica Miglietta, et al.
Pageof 1